Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Feb;19(2):217-229.
doi: 10.1007/s11695-008-9696-3. Epub 2008 Sep 27.

Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Mousumi Bose  1   2 , Blanca Oliván  3 , Julio Teixeira  4 , F Xavier Pi-Sunyer  3 , Blandine Laferrère  3
Affiliations
Review

Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Mousumi Bose et al. Obes Surg. 2009 Feb.

Abstract

Gastric bypass surgery (GBP), in addition to weight loss, results in dramatic remission of type 2 diabetes (T2DM). The mechanisms by which this remission occurs are unclear. Besides weight loss and caloric restriction, the changes in gut hormones that occur after GBP are increasingly gaining recognition as key players in glucose control. Incretins are gut peptides that stimulate insulin secretion postprandially; the levels of these hormones, particularly glucagon-like peptide-1, increase after GBP in response to nutrient stimulation. Whether these changes are causal to changes in glucose homeostasis remain to be determined. The purpose of this review is to assess the evidence on incretin changes and T2DM remission after GBP, and the possible mechanisms by which these changes occur. Our goals are to provide a thorough update on this field of research so that recommendations for future research and criteria for bariatric surgery can be evaluated.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representation of gastric banding (a) and gastric bypass (b). Graphics courtesy of Packard Children's Hospital, Palo Alto, CA, USA
Fig. 2
Fig. 2
Proposed model for mechanisms of T2DM remission after GBP based on available studies. Dashed lines indicate hypothetical links
See this image and copyright information in PMC

References

    1. Surgery ASMBS . Press release 8/22/2007: metabolic surgery expected to play bigger role in treating type 2 diabetes and other metabolic diseases. Gainesville, FL: 2007. [updated 2007; cited]; Available from: http://www.asbs.org/Newsite07/resources/press_release_8202007.pdf (2007)
    1. Zhao Y, Encinosa W, Quality AfHRa . Bariatric surgery utilization and outcomes in 1998 and 2004: statistical brief #23. Agency for Healthcare Research and Quality; Rockville: 2007. [updated 2007; cited 2008 May 9]; Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb23.pdf. - PubMed
    1. Anonymous Methods for voluntary weight loss and control. Ann Intern Med; NIH Technology Assessment Conference Panel. Consensus Development Conference; 30 March to 1 April 1992; 1993. pp. 764–70. - PubMed
    1. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37. - PubMed
    1. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23. - PubMed

Publication types

MeSH terms